NovoCure Ltd. (NVCR)
Market Closed
17 Jul, 20:00
$
15. 92
-0.5
-3.0451%
$
1.84B Market Cap
- P/E Ratio
- Div Yield
856,300 Volume
-2.03 Eps
$ 16.42
Previous Close 
Want to track NVCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NovoCure Ltd. (NVCR) Statistics
Valuation metrics
Market Cap 1.84B
Enterprise value 1.98B
Trailing P/E (ttm) -10.41
Forward P/E -15.33
PEG ratio 0.78
Price/Sales (ttm) 2.73
Price/Book (mrq) 5.49
Enterprise Value/Revenue 2.94
Enterprise Value/EBITDA -12.75
Overview
Shares outstanding 115.82M
Float 95.36M
Shares short 6.97M
% Held by insiders 0.1%
% Held by institutions 0.88%
Average volume (10 days) 676.5K
Average volume (90 days) 1.74M
Price summary
52-Week low 9.82
52-Week high 18.92
Beta 0.9
50-Day moving average 16.22
200-Day moving average 13.36
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.26%
Operating margin -0.27%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.51%
Income Statement
Revenue (ttm) 674.41M
Revenue per share (ttm) 5.91
Quarterly revenue growth (yoy) 0.12%
Gross profit (ttm) 508.84M
EBITDA -166.22M
Net income to common (ttm) -173.05M
Diluted EPS (ttm) -1.52
Quarterly earnings growth (yoy) 0.12%
Balance Sheet
Total cash (mrq) 432M
Total cash per share (mrq) 3.87
Total debt (mrq) 234.94M
Total Debt/Equity (mrq) 0.71
Current ratio (mrq) 2.9%
Book value per share (mrq) 2.9
Cash Flow
Cash flow statement -26.88M
Levered free cash flow (LFCF) 5.08M
